Hiroyoshi Horikoshi

5.6k total citations · 2 hit papers
57 papers, 4.6k citations indexed

About

Hiroyoshi Horikoshi is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Hiroyoshi Horikoshi has authored 57 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Physiology. Recurrent topics in Hiroyoshi Horikoshi's work include Metabolism, Diabetes, and Cancer (12 papers), Adipose Tissue and Metabolism (12 papers) and Pancreatic function and diabetes (9 papers). Hiroyoshi Horikoshi is often cited by papers focused on Metabolism, Diabetes, and Cancer (12 papers), Adipose Tissue and Metabolism (12 papers) and Pancreatic function and diabetes (9 papers). Hiroyoshi Horikoshi collaborates with scholars based in Japan, United States and Germany. Hiroyoshi Horikoshi's co-authors include Toshihiko Fujiwara, Shinji Yoshioka, Takuya Fujiwara, Takao Yoshioka, Akira Okuno, Takashi Kadowaki, Hiroyuki Tamemoto, Izumi Ushiyama, Kazuhiko Umesono and Kohjiro Ueki and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hiroyoshi Horikoshi

55 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

1998 875 citations Akira Okuno, Hiroyuki Tamemoto et al. Journal of Clinical Investigation profile →
Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1

1994 859 citations Hiroyuki Tamemoto, Takashi Kadowaki et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroyoshi Horikoshi Japan	24	2.7k	1.4k	1.2k	908	827	57	4.6k
Ripudaman S. Hundal United States	10	2.2k 0.8×	1.7k 1.2×	1.3k 1.1×	1.2k 1.3×	827 1.0×	10	4.2k
Todd Leff United States	36	2.5k 0.9×	1.3k 0.9×	634 0.5×	648 0.7×	768 0.9×	57	4.2k
Cristina M. Rondinone United States	37	2.7k 1.0×	1.5k 1.1×	997 0.9×	925 1.0×	796 1.0×	74	4.8k
Jerry R. Colca United States	40	2.9k 1.1×	1.1k 0.8×	1.1k 0.9×	1.2k 1.3×	1.2k 1.4×	115	5.0k
I. George Fantus Canada	36	2.2k 0.8×	903 0.6×	925 0.8×	509 0.6×	676 0.8×	66	4.5k
Mark A. Deeg United States	30	1.9k 0.7×	725 0.5×	1.5k 1.3×	1.2k 1.3×	945 1.1×	84	4.1k
Kathleen K. Brown United States	20	2.1k 0.8×	1.0k 0.7×	529 0.5×	951 1.0×	862 1.0×	27	4.0k
I. George Fantus Canada	38	3.8k 1.4×	1.3k 0.9×	1.1k 0.9×	822 0.9×	1.0k 1.3×	71	6.6k
John Ventre United States	14	4.3k 1.6×	1.6k 1.1×	1.5k 1.3×	1.2k 1.3×	1.8k 2.1×	18	6.2k
Bingbing Jiang United States	29	2.6k 1.0×	1.4k 1.0×	701 0.6×	1.1k 1.2×	705 0.9×	42	4.9k

Countries citing papers authored by Hiroyoshi Horikoshi

Since Specialization

Citations

This map shows the geographic impact of Hiroyoshi Horikoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyoshi Horikoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyoshi Horikoshi more than expected).

Fields of papers citing papers by Hiroyoshi Horikoshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyoshi Horikoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyoshi Horikoshi. The network helps show where Hiroyoshi Horikoshi may publish in the future.

Co-authorship network of co-authors of Hiroyoshi Horikoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyoshi Horikoshi. A scholar is included among the top collaborators of Hiroyoshi Horikoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyoshi Horikoshi. Hiroyoshi Horikoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okada, Makoto, Koji Suzuki, Mika Matsumoto, et al.. (2009). Effects of angiotensin on the expression of fibrosis-associated cytokines, growth factors, and matrix proteins in human lung fibroblasts. Journal of Clinical Pharmacy and Therapeutics. 34(3). 289–299. 16 indexed citations

Shimizu, Kyoko, Keiko Shiratori, Naoaki Hayashi, et al.. (2002). Thiazolidinedione Derivatives as Novel Therapeutic Agents to Prevent the Development of Chronic Pancreatitis. Pancreas. 24(2). 184–190. 43 indexed citations

Shimizu, Kyoko, Keiko Shiratori, Naoaki Hayashi, Takuya Fujiwara, & Hiroyoshi Horikoshi. (2000). Effect of Troglitazone on Exocrine Pancreas in Rats with Streptozotocin-Induced Diabetes Mellitus. Pancreas. 21(4). 421–426. 15 indexed citations

Fujiwara, Takuya & Hiroyoshi Horikoshi. (2000). Troglitazone and related compounds. Life Sciences. 67(20). 2405–2416. 55 indexed citations

Yoshida, Yumiko, et al.. (1999). Inhibition of Galactose-Induced Cataractogenesis by Troglitazone, a New Antidiabetic Drug with an Antioxidant Property, in Rat Lens Culture. Journal of Ocular Pharmacology and Therapeutics. 15(1). 73–83. 3 indexed citations

Nakajima, Katsuyoshi, et al.. (1998). Synthesis and 5α-reductase inhibitory activities of benzofuran derivatives with a carbamoyl group. Bioorganic & Medicinal Chemistry Letters. 8(6). 561–566. 12 indexed citations

Okuno, Akira, Hiroyuki Tamemoto, Kohjiro Ueki, et al.. (1998). Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.. Journal of Clinical Investigation. 101(6). 1354–1361. 875 indexed citations breakdown →

Takahashi, Sayaka, et al.. (1998). Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats. Life Sciences. 63(22). 2039–2047. 26 indexed citations

Okuno, Akira, K. Ikeda, Masakazu Shiota, et al.. (1997). Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb. Metabolism. 46(6). 716–721. 22 indexed citations

10.

Masuda, Keiko, Yoshimasa Okamoto, Yoshiyuki Tsuura, et al.. (1995). Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide. Diabetologia. 38(1). 24–30. 59 indexed citations

11.

Ohsumi, Jun, Sachiko Sakakibara, Junna Yamaguchi, et al.. (1994). Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells.. Endocrinology. 135(5). 2279–2282. 92 indexed citations

12.

Kurata, Hitoshi, et al.. (1994). Synthesis of B-NOR-4-AZA-5α-androstane compound as 5α-reductase inhibitor. Bioorganic & Medicinal Chemistry Letters. 4(5). 729–732. 4 indexed citations

13.

Tamemoto, Hiroyuki, Takashi Kadowaki, Kazuyuki Tobe, et al.. (1994). Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372(6502). 182–186. 859 indexed citations breakdown →

14.

Fujiwara, Toshihiko, Mikiyo Wada, Kuniaki Fukuda, et al.. (1991). Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in - mice. Metabolism. 40(11). 1213–1218. 101 indexed citations

15.

Tanase, Hisao, et al.. (1991). Inherited primary hypothyroidism with thyrotrophin resistance in Japanese cats. Journal of Endocrinology. 129(2). 245–NP. 23 indexed citations

16.

Yoshioka, Takao, et al.. (1989). Studies on hindered phenols and analogs. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation. Journal of Medicinal Chemistry. 32(2). 421–428. 190 indexed citations

17.

Fujiwara, Takuya, et al.. (1986). Effects of new hypoglycemic agent 2-piperazinyl-4-methyl-amino-5-methylthieno [2,3-d]pyrimidine dihydrochloride hydrate.. PubMed. 36(12). 1770–4. 1 indexed citations

18.

Horikoshi, Hiroyoshi, et al.. (1979). Progesterone and estradiol-17β contents in ovarian cyst-fluid and normal follicular fluid in the cow. Kachiku hanshokugaku zasshi. 25(3). 141–143. 1 indexed citations

19.

Horikoshi, Hiroyoshi & Walter G. Wiest. (1971). Interrelationships Between Estrogen and Progesterone Secretion and Trauma-Induced Deciduomata. On Causes of Uterine Refractoriness in the “Parlow Rat”1. Endocrinology. 89(3). 807–817. 18 indexed citations

20.

Horikoshi, Hiroyoshi, et al.. (1970). Estrogen secretion by the superovulated rat ovary.. PubMed. 86(6). 1454–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact